Lung-I Cheng

Vice President, Cell and Gene Therapy • AmerisourceBergen

Lung-I Cheng is Vice President, Cell and Gene Therapy, leading AmerisourceBergen’s Cell and Gene Therapy (CGT) service line within Commercial Solutions.

He is responsible for leading a unified CGT go-to-market strategy that addresses external customer needs, and provides integrated solutions that deliver the right resources at the right time to position therapies for success.

Before joining AmerisourceBergen, he spent a decade in biopharma and most recently led Takeda Oncology’s global value and access team in cell therapies and pipeline.

Also Speaking

Ian Goodwin

Director, Global Program Design, • Fujifilm Diosynth Biotechnologies

Peter Peumans

Gregg Nyberg

Chief Technology Officer • Landmark Bio

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.